444 related articles for article (PubMed ID: 31619220)
21. Calcitonin negative medullary thyroid cancer in ectopic thyroid tissue: a rare diagnosis in an unusual location.
Montgomery G; Collins L; Coghlin C; Ullah R
BMJ Case Rep; 2020 Aug; 13(8):. PubMed ID: 32816938
[TBL] [Abstract][Full Text] [Related]
22. Surgical strategy for the treatment of sporadic medullary thyroid carcinoma: our experience.
Lupone G; Antonino A; Rosato A; Zenone P; Iervolino EM; Grillo M; De Palma M
G Chir; 2012; 33(11-12):395-9. PubMed ID: 23140924
[TBL] [Abstract][Full Text] [Related]
23. Medullary thyroid cancer outcomes in patients with undetectable versus normalized postoperative calcitonin levels.
Fanget F; Demarchi MS; Maillard L; Lintis A; Decaussin M; Lifante JC
Br J Surg; 2021 Sep; 108(9):1064-1071. PubMed ID: 33899100
[TBL] [Abstract][Full Text] [Related]
24. Calcitonin-negative medullary thyroid carcinoma: the 'triple-negative' phenotype.
Murphy DC; Johnson SJ; Aspinall S
Ann R Coll Surg Engl; 2020 Mar; 102(3):e63-e66. PubMed ID: 31841033
[TBL] [Abstract][Full Text] [Related]
25. Long-Term Follow-up in Medullary Thyroid Carcinoma.
Raue F; Frank-Raue K
Recent Results Cancer Res; 2015; 204():207-25. PubMed ID: 26494391
[TBL] [Abstract][Full Text] [Related]
26. Mild to moderate increase of serum calcitonin levels only in presence of large medullary thyroid cancer deposits.
Pelizzo MR; Torresan F; Da Roit A; Merante Boschin I; Chondrogiannis S; Rampin L; Colletti PM; Vinjamury S; Perkins AJ; Rubello D
Rev Esp Med Nucl Imagen Mol; 2015; 34(6):378-82. PubMed ID: 26420439
[TBL] [Abstract][Full Text] [Related]
27. Clinical review: Incidentally discovered medullary thyroid cancer: diagnostic strategies and treatment.
Ahmed SR; Ball DW
J Clin Endocrinol Metab; 2011 May; 96(5):1237-45. PubMed ID: 21346073
[TBL] [Abstract][Full Text] [Related]
28. Diagnosis and pathologic characteristics of medullary thyroid carcinoma-review of current guidelines.
Thomas CM; Asa SL; Ezzat S; Sawka AM; Goldstein D
Curr Oncol; 2019 Oct; 26(5):338-344. PubMed ID: 31708652
[TBL] [Abstract][Full Text] [Related]
29. Clinico-pathological and prognostic findings on 27 cases of medullary thyroid carcinoma.
Gabsi A; El Amine El Hadj O; Goucha A; Said G; Laabidi B; Gamoudi A
Tunis Med; 2017 Feb; 95(2):97-102. PubMed ID: 29424867
[TBL] [Abstract][Full Text] [Related]
30. [Total thyroidectomy in C-cell hyperplasia of the thyroid gland].
Stojanović D; Paunović I; Caparević Z; Lalosević D; Stojanović M
Med Pregl; 2003; 56(9-10):481-4. PubMed ID: 14740541
[TBL] [Abstract][Full Text] [Related]
31. Calcitonin and complementary biomarkers in the diagnosis of hereditary medullary thyroid carcinoma in children and adolescents.
Eckelt F; Pfaeffle R; Kiess W; Kratzsch J
J Pediatr Endocrinol Metab; 2021 Dec; 34(12):1491-1504. PubMed ID: 34543539
[TBL] [Abstract][Full Text] [Related]
32. An Unusual Case of Medullary Thyroid Carcinoma and A Revision of Current Literature.
Cipri C; Vescini F; Torresan F; Pennelli G; Pelizzo MR; Triggiani V; Guastamacchia E; Grimaldi F
Endocr Metab Immune Disord Drug Targets; 2019; 19(2):226-229. PubMed ID: 30574858
[TBL] [Abstract][Full Text] [Related]
33. [Progression of diagnosis and treatment of medullary thyroid carcinoma].
Wang X; Li C; Huang L; Shui CY; Liu W; Cai YC; Sun RH; Zhou YQ; Jiang J; Wang W; Zeng DF
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2019 Apr; 54(4):306-310. PubMed ID: 30991785
[No Abstract] [Full Text] [Related]
34. Molecular signatures of medullary thyroid carcinoma by matrix-assisted laser desorption/ionisation mass spectrometry imaging.
Smith A; Galli M; Piga I; Denti V; Stella M; Chinello C; Fusco N; Leni D; Manzoni M; Roversi G; Garancini M; Pincelli AI; Cimino V; Capitoli G; Magni F; Pagni F
J Proteomics; 2019 Jan; 191():114-123. PubMed ID: 29581064
[TBL] [Abstract][Full Text] [Related]
35. A Review of the Significance in Measuring Preoperative and Postoperative Carcinoembryonic Antigen (CEA) Values in Patients with Medullary Thyroid Carcinoma (MTC).
Passos I; Stefanidou E; Meditskou-Eythymiadou S; Mironidou-Tzouveleki M; Manaki V; Magra V; Laskou S; Mantalovas S; Pantea S; Kesisoglou I; Sapalidis K
Medicina (Kaunas); 2021 Jun; 57(6):. PubMed ID: 34208296
[No Abstract] [Full Text] [Related]
36. A Nationwide Study of Multiple Endocrine Neoplasia Type 2A in Norway: Predictive and Prognostic Factors for the Clinical Course of Medullary Thyroid Carcinoma.
Opsahl EM; Brauckhoff M; Schlichting E; Helset K; Svartberg J; Brauckhoff K; Mæhle L; Engebretsen LF; Sigstad E; Grøholt KK; Akslen LA; Jørgensen LH; Varhaug JE; Bjøro T
Thyroid; 2016 Sep; 26(9):1225-38. PubMed ID: 27400880
[TBL] [Abstract][Full Text] [Related]
37. Clinical utility of genetic diagnosis for sporadic and hereditary medullary thyroid carcinoma.
Elisei R; Bottici V; Cappagli V; Ramone T; Tacito A; Ciampi R; Romei C
Ann Endocrinol (Paris); 2019 Jun; 80(3):187-190. PubMed ID: 31053251
[TBL] [Abstract][Full Text] [Related]
38. [PREOPERATIVE DIAGNOSTICS OF THYROID MEDULLARY CARCINOMA WITH EMPHASIS ON CYTOMORPHOLOGICAL FEATURES AND DIFFERENTIAL DIAGNOSIS OF PRIMARY AND SECONDARY THYROID TUMORS].
Katović SK; Vasilj A
Acta Med Croatica; 2014 Dec; 68(4-5):383-8. PubMed ID: 26285471
[TBL] [Abstract][Full Text] [Related]
39. Prevalence and clinical spectrum of nonsecretory medullary thyroid carcinoma in a series of 839 patients with sporadic medullary thyroid carcinoma.
Frank-Raue K; Machens A; Leidig-Bruckner G; Rondot S; Haag C; Schulze E; Lorenz A; Kreissl MC; Dralle H; Raue F; Schmid KW
Thyroid; 2013 Mar; 23(3):294-300. PubMed ID: 22946486
[TBL] [Abstract][Full Text] [Related]
40. False-positive staining of thyroglobulin distinguished from mixed medullary and follicular thyroid carcinoma by duplex in situ hybridization.
Takeshima K; Ariyasu H; Uraki S; Morita S; Furukawa Y; Inaba H; Iwakura H; Doi A; Warigaya K; Murata SI; Enomoto K; Hotomi M; Akamizu T
Endocr J; 2020 Oct; 67(10):1007-1017. PubMed ID: 32522910
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
